Heat shock protein 70 has been recognized as a target for anticancer therapy. The overexpression of heat shock protein 70 is observed frequently in several types of tumors, including breast cancer. It is involved with increased cell proliferation, poor prognosis, and drug resistance in breast cancer. VER-155008 is an effective inhibitor of heat shock protein 70 that targets the adenosine triphosphatase-binding domain of heat shock protein 70. In this study, the effects of VER-155008, heat shock (43 C, 1 hour), and the combination treatment of VER-155008 and heat shock on the mitochondria of the MCF-7 breast cancer cells were investigated through a laser scanning microscope combined with mitochondrial membrane potential fluorescence probe. We observed broken mitochondria networks, decreased mitochondrial membrane potential, and cell size. The mitochondrial contents were reduced with the VER-155008 treatment and the combination treatment of VER-155008 and heat shock. The effects of the inhibition presented treatment time dependence. Moreover, the effect of the inhibition of the sole VER-155008 was alleviated when it was combined with heat shock although there was no obvious change with the sole heat shock treatment. The results indicated that VER-155008, the inhibitor of heat shock protein 70, induced apoptosis in MCF-7 breast cancer cells whatever it was in the sole or the combined manner, and its promoting apoptosis effect could be alleviated by heat shock. Our findings demonstrated that HSP70 can be a good target for developing breast cancer therapy.
Introduction
Heat shock proteins (HSPs) are ubiquitous and highly conserved proteins that are principally stimulated by HS and other stresses in a wide range of species. 1 The HSPs have been described as molecular chaperones that assist in protein folding, modification, and transportation. 2, 3 The HSP70 family is a basic member of HSPs, and it distributes mainly in the cytoplasm, the mitochondria, the endoplasmic reticulum, and the cell nucleus. The HSP70 prevents protein aggregation and refolds unfolded or denatured proteins via ATPase activity in case of stress response. 4 Rapid expression of HSP70 in response to cellular stress, including HS, can occur in minutes. It plays an important role in protection against stress-induced apoptosis because of its increased expression and contribution to life-sustaining mechanisms of cells. 5 Accumulating evidence has demonstrated that the overexpression of HSP70 is observed frequently in several types of 1 
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Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, China tumors, including breast cancer. [6] [7] [8] The overexpression of HSP70 can provide a selective survival advantage to tumor cells in part due to its ability to inhibit multiple pathways of cell death, including intrinsic and extrinsic apoptosis. 9 And high HSP70 levels predicted lower response of breast cancers to radiation, hyperthermia, and antitumor drug. 10, 11 Moreover, the overexpression of HSP70 in breast cancer is often involved with increased cell proliferation, poor prognosis, and drug resistance. 8 The HSP70 has attracted plenty of attention, and the inhibition of HSP70 is believed to be a promising path in antitumor therapy. [12] [13] [14] Some compounds that specifically target HSP70 have been invented and have exhibited their antiproliferative activity against cancer but not normal cells. [15] [16] [17] VER-155008 is an effective HSP70 family inhibitor that targets the ATPase binding domain of HSP70. Previous reports indicated that this ATP analog induced apoptosis in BT474 breast cancer cells and HCT116 colon carcinoma cells 18 and inhibited proliferation and cell cycle progression significantly in non-small cell lung cancer cells. 19 In this study, the effect of VER-155008 on the mitochondria of MCF-7 breast cancer cells was investigated by a laser scanning microscope equipped with a high numerical aperture (NA) oil objective. We pay our attention to the changes in mitochondria because the mitochondria are the critical elements in response of cellular stress and play an important role in the progression of apoptosis. In addition, the effects of the HS and the combination of VER-155008 and HS on the mitochondria of MCF-7 breast cancer cells were also investigated by membrane potential-dependent fluorescence labeling. The mitochondrial morphology was visualized, and the mitochondrial membrane potential (DC m ), the mitochondrial content, and the cell size were quantified through the potential sensor 5,5',6,6'-Tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1).
Materials and Methods

Cell Culture
MCF-7 human breast cancer cell line was purchased from Keygen (Nanjing, China). Cells were cultured in Dulbecco's Modified Eagle Medium (Hyclone, Iogan, Utah) supplemented with 10% (vol/vol) heat-inactivated fetal bovine serum (Hyclone), 1% antibiotic-antimycotic solution with 100 U/mL of penicillin and 100 mg/mL of streptomycin (Gibco, Grand Island, New York), and was grown in a humidified incubator (Thermo Fisher Scientific, Waltham, Mass) with 5% CO 2 under 37 C. The cells were digested with 0.25% trypsin when the cell abundance was about 80% to 90%. To prepare for the laser scanning microscopy imaging, the single cell suspension was seeded into the 4-chamber glass bottom dishes (35 mm) at a density of 4000 cells/well. Then, the cells were submitted to subsequent experimental processing after keeping in the incubator for 24 hours.
HSP70 Inhibitor and Heat Shock Treatments
Heat Shock Protein 70 inhibitor VER-155008 (Selleck, Houston, Texas) was dissolved with dimethylsulfoxide and diluted in fresh supplemented culture medium at an end concentration of 20 mmol/L for experiment. Heat shock treatment was performed in an incubator (Heal Force, Shanghai, China) with 5% CO 2 under 43 C for 1 hour. Then, the cells were kept in the incubator (Thermo) with 5% CO 2 under 37 C for 24, 48, and 72 hours, respectively, after the beginning of inhibitor treatment and/or HS treatment. In all experiments, the MCF-7 breast cancer cells without VER-155008 and HS treatments were as control groups.
Mitochondrial Fluorescence Labeling
The mitochondrial membrane potential sensor JC-1 (Sigma, Saint Louis, Missouri) was used to label mitochondria. The JC-1 is a one-excitation and dual-emission peaks potential-sensitive probe for DC m measurement. It forms green fluorescence monomers at low DC m while accumulates as red fluorescence J-aggregates at high DC m . MCF-7 breast cancer cells in the 4-chamber glass bottom dishes were washed with phosphatebuffered saline (PBS) twice and incubated with 5 mmol/L JC-1 solution for 30 minutes in an incubator with 5% CO 2 at 37 C. Then the cells were prepared for microscopy imaging after 3 washes with PBS.
Confocal Microscopy Imaging
A schematic diagram for fluorescence imaging was shown in Figure 1 . An inverted laser scanning microscope (TCS SP8, Leica, Germany) equipped a 100Â oil objective (NA ¼ 1.4) was employed to visualize the mitochondria of MCF-7 breast cancer cells. A 488-nm laser was used as excitation light source for mitochondrial fluorescence imaging. In the beam path, the disturbance of excitation light to the fluorescence signal was blocked by a dichroic mirror. A tunable prism-based spectral detection system for 2-channel reflectance fluorescence imaging was used to select the detection wavelength range, covering from 400 to 800 nm. The green fluorescence channel with an extremely light-sensitive HyD detector: 505 to 540 nm, and the red fluorescence channel with a photomultiplier tube (PMT) detector: 565 to 610 nm. Moreover, another PMT for transmittance bright field detection was employed to distinguish the outline of interested cells. According to the experimental content, the acquisition image for DC m analysis was 512 Â 512 pixels, zoom ¼ 1, but for the mitochondrial morphology analysis was 1024 Â 1024 pixels, zoom ¼ 2.
Data and Statistics
The ratio of fluorescence intensities measured in the red fluorescence, and the green fluorescence detection channels was employed to calculate the mitochondrial membrane potential DC m ¼ I R = I G by a custom-made LAS AF software. I R and I G indicated the mean fluorescence intensities of the same cell in the red fluorescence and the green fluorescence channels, respectively.
All experimental values were presented as means (standard deviation). Statistical comparisons were made using 1-way analysis of vriance, Students Neuman-Keuls multiple comparisons (SPSS, version16.0, http://www.spss.com). P < .05 was considered to be significant.
Results and Discussion
Fluorescence Imaging of Mitochondria G showed the cultivation time of cells at 24, 48, and 72 hours after the beginning of the treatments, respectively. We found that the mitochondrial networks of MCF-7 cells were intact, extended, and covering the majority of the cells in control cells and the sole HS cells, while they were both shrinkage, damaged, and fragmented dramatically from long filamentous interconnected tubules into short tubules with the VER-155008 treatment and the combination treatment. The changes in mitochondria morphologies were in accordance with the descriptions of cell apoptosis. 20 Moreover, the mitochondrial contents were changed in the VER-155008 treatment and the combination treatment. Finally, the changes in the damaged mitochondrial morphologies of MCF-7 cells were more obvious with increasing treatment time.
Measurement of the Mitochondrial Membrane Potential
The ratio of fluorescence intensities measured in the red fluorescence and the green fluorescence detection channels described DC m and can be used to character the physiological or pathological state of the cells. DC m after VER-155008, HS, and the combination treatment of VER-155008 and HS were calculated as shown in Figure 3A , and the ratio of DC m of treatment cells to that of control cells was showed in Figure  3B . We found that DC m were decreased significantly with the VER-155008 treatment and the combination treatment These results indicated that the inhibition of HSP70 contributed to the decrease of DC m in MCF-7 breast cancer cells with the sole HSP70 inhibitor VER-155008 treatment and the combination treatment. Heat shock treatment not influenced DC m obviously but alleviated the depolarization effect on DC m when it was combined with VER-155008. Therefore, we concluded that the obvious decrease in DC m induced by the inhibition of HSP70 may imply the cell apoptosis in MCF-7 breast cancer cells. 21 The HS-induced effect alleviates the inhibition effect of VER-155008.
Measurement of the Mitochondrial Content
DC m was relate to the fluorescence intensities in the red fluorescence and the green fluorescence channels. Many researchers usually pay more attention to the ratio of the red and the green fluorescence intensities than themselves. And the fluorescence intensity influenced by mitochondrial content and the cell size usually presented as mean value in a cell. It might not suit to describe the mitochondrial content when the cell size was changed. In our study, the pixel sum that specified the sum of the measured gray-scale values was used to assess the effects of VER-155008, HS, and the combination treatment on the mitochondrial content ( Figure 4A, C, and E) . It demonstrated the pixel sum in the green fluorescence, the red fluorescence, and the overlay fluorescence channels were reduced obviously with the sole VER-155008 treatment and the combination treatment. The ratios of average pixel sums of the treatment cells to those of the control cells were used to evaluate the decrease degree in mitochondrial contents ( Figure 4B , D, and F). In the green fluorescence channel, the ratios were 0.84 (0.20), 0.83 (0.24), and 0.59 (0.13) between the VER-155008 treatment cells and the control cells, and they were These data depicted the changes in mitochondrial contents with the VER-155008 treatment and the combination treatment in 3 fluorescence channels. The mitochondrial contents with the combination treatment were both more than those with the sole VER-155008 treatment in the red fluorescence and the overlay fluorescence channels, while those were not like that in the green fluorescence channel. Moreover, the decrease in mitochondrial contents presented treatment time dependence in the red fluorescence and the overlay fluorescence channels, but it was not like that in the green fluorescence channel. We considered that these phenomena might ascribe to the conversion of DC m from high state to low state. The decrease in the highly polarized mitochondria contents might induce the increase in the mitochondrial contents of low DC m . Meanwhile, the decrease in the total mitochondrial contents might due to the dissociation of mitochondria when the VER-155008 treatment or the combination treatment was employed. In addition, the mitochondria contents had no statistical discrepancies between the HS treatment cells and the control cells in any fluorescence channels.
Measurement of the Cell Size
Further measurement was employed to investigate the size changes in MCF-7 breast cancer cells after VER-155008, HS, and the combination treatment. The results were shown in Figure 5 . The average cell areas decreased significantly with the VER-155008 treatment and the combination treatment at 24, 48, and 72 hours after the beginning of the treatments. In addition, there were no obvious discrepancies between the HS treatment cells and the control cells at 3 different measurement times. These results might further indicate that the inhibition of HSP70 induced MCF-7 cells apoptosis because the cell shrinkage was considered as one of the events of cell apoptosis.
Conclusion
The effects of the treatments of VER-155008, HS, and the combination of VER-155008 and HS on the mitochondrial morphology, DC m , the mitochondrial content, and the cell size were investigated in JC-1 labeled MCF-7 breast cancer cells at 24, 48, and 72 hours after the beginning of the treatments. A laser scanning microscope equipped with a high NA oil objective was employed to visualize the changes in mitochondrial morphology and cell size. The ratio of fluorescence intensities measured in the red fluorescence and the green fluorescence detection channels was used to calculate DC m . Meanwhile, the pixel sums were utilized to describe the changes in the mitochondrial contents in the red fluorescence (the mitochondrial contents of high DC m ), the green fluorescence (the mitochondrial contents of low DC m ), and the overlay fluorescence channels (the total mitochondrial contents), respectively.
The results revealed that the sole HSP70 inhibitor VER-155008 treatment and the combination treatment of VER-155008 and HS both caused some apoptosis-related phenomena in MCF-7 breast cancer cells. The intact networks of mitochondria were broken, DC m and cell size were decreased, and the mitochondrial contents were reduced. These indicated that the inhibition of HSP70 by VER-155008 might effectively induce apoptosis in MCF-7 breast cancer cells, and the effect of the inhibition of HSP70 was treatment time dependence. Moreover, it was worth noting that the sole HS treatment not induced obvious change in mitochondria of MCF-7 breast cancer cells but alleviated the promoting apoptosis effect of VER-155008 at the condition of the combination treatment. We considered it might in part attribute to the protective function of HSP70 and may be other HSPs induced by HS. In conclusion, we visualize and quantify the effect of the inhibition of HSP70 on breast cancer cells based on laser scanning microscopy. Our findings demonstrated that VER-155008, the inhibitor of HSP70, induced the apoptosis of MCF-7 breast cancer cells, and its inhibition effect was alleviated by HS.
So far, most of the researches of the anticancer therapy targeted HSP70 were employed in vitro cells. The inhibition of HSP70 has shown its proapoptosis effect in many cancer cells. In vivo, VER-155008 demonstrated rapid metabolism and clearance in the HCT116 tumor-bearing mouse, along with tumor levels below the predicted pharmacologically active level. 18 Therefore, VER-155008 encapsulated in the nanoparticle may result in significantly higher cellular retention than treatment with it in solution, and it would be a good solution for our next in vivo experiments.
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